Thierry Laugel

Thierry Laugel
Managing Partner and Chairman of the Management Board
Company: 
Kurma Partners

Thierry co-founded Kurma in 2009. He has 25 years of experience in the Life Science Venture industry and is a Pharmacist and PhD by training. Thierry started his career in Japan as a scientific representative for Laboratoires Fournier (1992-1996). Having then studied at Insead, he joined Flamel Technologies as project director for Pharmaceutical R&D, after its IPO on the Nasdaq (1997-1998). He then moved to the investment world, first at Caisse des Dépots (1998-2005), then to AGF Private Equity (2005-2009), where he supervised the healthcare investment team. Thierry led investments in companies like Actelion, Arpida, Targacept, Adocia, Auris, Erytech or Safe Orthopaedics. He is currently on the Board of Directors of Meiogenix, Pathoquest, Blink Biomedical, Asarina Pharma and Minoryx.